1H-Pyrrolo[2,3-b]pyridin-5-ol

We are 1H-Pyrrolo[2,3-b]pyridin-5-ol CAS:98549-88-3 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name: 1H-Pyrrolo[2,3-b]pyridin-5-ol
CAS.NO:  98549-88-3
Synonyms:5-Hydroxy-7-azaindole

Molecular Formula:  C8H8N2O
Molecular Weight:148.16200

Physical and Chemical Properties:
Density: 1.4±0.1 g/cm3
Boiling point: 369.7±22.0 °C at 760 mmHg
Melting point: 219-220ºC
Flash point: 177.4±22.3 °C
Refractive index: 1.760

Specification:
Appearance:White to off-white powder
Purity:≥98.0%
Single impunity:≤0.15%
Other impunity:≤0.1%
Water content(KF):0.50%(max.)

Packing:
 25kg 1 cardboard drum or according to customer specified requirements
Storage:Shade light and keep tightly closed
Application: Intermediates of ABT-199 CAS:1257044-40-8.

1H-Pyrrolo[2,3-b]pyridin-5-ol


Related News: The upstream of pharmaceutical intermediates is the basic chemical raw material industry. Basic chemical raw materials are bulk commodities and prices fluctuate greatly, which directly affects the production costs of enterprises.1-Phenyl-5-pyrazolone-3-carboxylic Acid CAS:119-18-6 The upstream of pharmaceutical intermediates is the basic chemical raw material industry. Basic chemical raw materials are bulk commodities and prices fluctuate greatly, which directly affects the production costs of enterprises.3-Carboxy-1-(4-sulfophenyl)-5-pyrazolone Sodium Salt CAS:52126-51-9 The drug review center will establish a registration platform and database for APIs, pharmaceutical excipients and pharmaceutical packaging materials, which means that the domestic drug substance DMF system is expected to be gradually implemented.462-72-6 As proof-of-principle for the unique advantages arising from selecting a single engineered iPSC clone for the production of CAR T-cell therapy, the scientists assessed 747 clones after engineering a pool of cells using CRISPR. It was found that only about 2% of clones met the Company’s standards for overall quality including containing both bi-allelic disruption of the TCR, proper insertion of the CAR into the TRAC locus without random transgene integrations, and no evidence of off-target genomic modifications or translocations.As proof-of-principle for the unique advantages arising from selecting a single engineered iPSC clone for the production of CAR T-cell therapy, the scientists assessed 747 clones after engineering a pool of cells using CRISPR. It was found that only about 2% of clones met the Company’s standards for overall quality including containing both bi-allelic disruption of the TCR, proper insertion of the CAR into the TRAC locus without random transgene integrations, and no evidence of off-target genomic modifications or translocations.

Related Products
Product Name
4-[(2-Aminoethyl)(5-chloro-2-benzoxazolyl)amino]-2-butanone methanesulfonate View Details
1-bromodibenzo[b,d]furan View Details
Ethyl (E)-3,5-dihydroxy-7-[2-cyclopropyl-4-(4-fluorophenyl)-3-quinolinyl]-hept-6-enoate View Details
2,3,5-Trimethylpyrazine manufacturer 2-Ethyl-4-methylimidazole manufacturer 5-(2-Hydroxyethylamino)-2-methoxylaniline sulfate manufacturer Ethenyldiethoxymethylsilane manufacturer (2S)-1-N-(2-aminoethyl)-3-(4-ethoxyphenyl)propane-1,2-diamine,trihydrochloride manufacturer